HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden.

Abstract
Several studies reported amyotrophic lateral sclerosis (ALS)-linked mutations in TBK1, OPTN, VCP, UBQLN2, and SQSTM1 genes encoding proteins involved in autophagy. SQSTM1 was originally identified by a candidate gene approach because it encodes p62, a multifunctional protein involved in protein degradation both through proteasomal regulation and autophagy. Both p62 and optineurin (encoded by OPTN) are direct interaction partners and substrates of TBK1, and these 3 proteins form the core of a genetic and functional network that may connect autophagy with ALS. Considering the molecular and conceptual relevance of the TBK1/OPTN/SQSTM1 "triangle," we here performed a targeted screen for SQSTM1 variants in 486 patients with familial ALS from Germany and Sweden by analyzing whole-exome sequencing data. We report 9 novel and 5 previously reported rare variants in SQSTM1 and discuss the current evidence for SQSTM1 as a primary disease gene for ALS. We conclude that the evidence for causality remains vague for SQSTM1 and is weaker than for the other autophagy genes, for example, TBK1 and OPTN.
AuthorsRüstem Yilmaz, Kathrin Müller, David Brenner, Alexander E Volk, Guntram Borck, Andreas Hermann, Thomas Meitinger, Tim M Strom, Karin M Danzer, Albert C Ludolph, Peter M Andersen, Jochen H Weishaupt, German ALS Network MND-NET
JournalNeurobiology of aging (Neurobiol Aging) Vol. 87 Pg. 139.e9-139.e15 (03 2020) ISSN: 1558-1497 [Electronic] United States
PMID31859009 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • SQSTM1 protein, human
  • Sequestosome-1 Protein
Topics
  • Amyotrophic Lateral Sclerosis (genetics)
  • Female
  • Genetic Variation
  • Germany
  • Humans
  • Male
  • Sequestosome-1 Protein (genetics)
  • Sweden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: